company background image
600521 logo

Zhejiang Huahai Pharmaceutical XSSC:600521 Stock Report

Last Price

CN¥12.99

Market Cap

CN¥19.1b

7D

0.7%

1Y

-37.5%

Updated

06 Apr, 2024

Data

Company Financials +

Zhejiang Huahai Pharmaceutical Co., Ltd.

XSSC:600521 Stock Report

Market Cap: CN¥19.1b

Zhejiang Huahai Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Huahai Pharmaceutical
Historical stock prices
Current Share PriceCN¥12.99
52 Week HighCN¥21.03
52 Week LowCN¥10.71
Beta0.12
1 Month Change-3.35%
3 Month Change-8.33%
1 Year Change-37.52%
3 Year Change-34.26%
5 Year Change-14.79%
Change since IPO45.12%

Recent News & Updates

Recent updates

Shareholder Returns

600521CN PharmaceuticalsCN Market
7D0.7%0.7%0.9%
1Y-37.5%-14.7%-16.5%

Rentabilidad frente al sector: 600521 obtuvo unos resultados inferiores a los del sector CN Pharmaceuticals , que el año pasado arrojó un rendimiento del -18.3%.

Rentabilidad vs. Mercado: 600521 obtuvo unos resultados inferiores a los del mercado CN, que fue del -22% el año pasado.

Price Volatility

Is 600521's price volatile compared to industry and market?
600521 volatility
600521 Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement7.2%
Market Average Movement8.3%
10% most volatile stocks in CN Market11.6%
10% least volatile stocks in CN Market5.2%

Precio estable de las acciones: 600521 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 600521 (5%) se ha mantenido estable durante el año pasado.

About the Company

FoundedEmployeesCEOWebsite
19897,682Bao Hua Chenhttps://www.huahaipharm.com

Zhejiang Huahai Pharmaceutical Co., Ltd. opera como empresa farmacéutica en China y a escala internacional. La empresa ofrece productos neurológicos centrales, cardiovasculares, antivirales y otros, así como API y productos intermedios. También suministra componentes de envasado, como botellas de polietileno de alta densidad y tapones de polipropileno para productos farmacéuticos.

Zhejiang Huahai Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Huahai Pharmaceutical's earnings and revenue compare to its market cap?
600521 fundamental statistics
Market capCN¥19.12b
Earnings (TTM)CN¥1.09b
Revenue (TTM)CN¥8.64b

17.5x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600521 income statement (TTM)
RevenueCN¥8.64b
Cost of RevenueCN¥3.47b
Gross ProfitCN¥5.16b
Other ExpensesCN¥4.07b
EarningsCN¥1.09b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 30, 2024

Earnings per share (EPS)0.74
Gross Margin59.78%
Net Profit Margin12.68%
Debt/Equity Ratio84.2%

How did 600521 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

32%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.